- Filed
- Mar 30, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 30, 2026 | 281.69M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 275.33M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 196.86M sh |
| Capex | FY 2025 · Dec 31, 2025 | $16.14K |
| Capex | FY 2025 · Dec 31, 2024 | $54.3K |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$2.33M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$1.47M |
| Long Term Debt | FY 2025 · Dec 31, 2025 | $43.7M |
| Long Term Debt | FY 2025 · Dec 31, 2024 | $40.48M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | −$49.77M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | −$45.51M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $17.43M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $31.34M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $63.21M |
| Total Liabilities restated | FY 2025 · Dec 31, 2024 | $80.14M |
| Current Assets | FY 2025 · Dec 31, 2025 | $1.58M |
| Current Assets | FY 2025 · Dec 31, 2024 | $13.68M |
| Total Assets | FY 2025 · Dec 31, 2025 | $19.84M |
| Total Assets | FY 2025 · Dec 31, 2024 | $42.32M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$0.02 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$0.35 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $5.51M |
| Sga Expense restated | FY 2025 · Dec 31, 2024 | $15.91M |
| Net Income | FY 2025 · Dec 31, 2025 | −$4.41M |
| Net Income restated | FY 2025 · Dec 31, 2024 | −$68.14M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$7.95M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$11.18M |
| Cost Of Revenue | FY 2025 · Dec 31, 2025 | $4.65M |
| Cost Of Revenue | FY 2025 · Dec 31, 2024 | $20.83M |